Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning

References

• Ebelt ND, Zamloot V, Zuniga E, et al. Collagenase-expressing salmonella targets major collagens in pancreatic cancer leading to reductions in immunosuppressive subsets and tumor growth. Cancers (Basel). 2021;13(14):3565–3565. doi: 10.3390/cancers13143565
   PubMed Web of Science ®Google Scholar
• Strohl MP, Raigani S, Ammori JB, et al. Surgery for localized pancreatic cancer: the trend is not improving. Pancreas. 2016;45(5):687–693. doi: 10.1097/MPA.0000000000000511
   PubMed Web of Science ®Google Scholar
• Gonzalez D, Stenzinger A. Homologous recombination repair deficiency (HRD): from biology to clinical exploitation. Genes Chromosomes Cancer. 2021;60(5):299–302. doi: 10.1002/gcc.22939
   PubMed Web of Science ®Google Scholar
• Heeke AL, Pishvaian MJ, Lynce F, et al. Prevalence of homologous recombination–related gene mutations across multiple cancer types. JCO Precis Oncol. 2018;2018(2):1–13. doi: 10.1200/PO.17.00286
   Google Scholar
• Ensminger M, Löbrich M. One end to rule them all: non-homologous end-joining and homologous recombination at DNA double-strand breaks. Br J Radiol. 2020;93(1115):20191054–20191054. doi: 10.1259/bjr.20191054
   PubMed Web of Science ®Google Scholar
• Knijnenburg TA, Wang L, Zimmermann MT, et al. Genomic and molecular landscape of DNA damage repair deficiency across the cancer Genome Atlas. Cell Rep. 2018;23(1):239–254. doi: 10.1016/j.celrep.2018.03.076
   PubMed Web of Science ®Google Scholar
• Lotan TL, Kaur HB, Salles DC, et al. Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Mod Pathol. 2021;34(6):1185–1193. doi: 10.1038/s41379-020-00731-4
   PubMed Web of Science ®Google Scholar
• Reardon DA, Brandes AA, Omuro A, et al. Effect of nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial. JAMA Oncol. 2020;6(7):1003–1010. doi: 10.1001/jamaoncol.2020.1024
   PubMed Web of Science ®Google Scholar
• Aiello MM, Solinas C, Santoni M, et al. Excision repair crosS complementation group 1 single nucleotide polymorphisms and nivolumab in advanced non-small cell lung cancer. Front Oncol. 2020;10:1167. doi: 10.3389/fonc.2020.01167
   PubMed Web of Science ®Google Scholar
• Chambon F, Osdoit S, Bagny K, et al. Dramatic response to nivolumab in xeroderma pigmentosum skin tumor. Pediatr Blood Cancer. 2018;65(2):65. doi: 10.1002/pbc.26837
   Web of Science ®Google Scholar
• Kraemer KH, Tamura D, Khan SG. Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers. Br J Dermatol. 2018;178(5):1009–1009. doi: 10.1111/bjd.16525
   PubMed Web of Science ®Google Scholar
• Jiang M, Jia K, Wang L, et al. Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021;11(10):2983–2994. doi: 10.1016/j.apsb.2021.01.003
   PubMed Web of Science ®Google Scholar
• Feng M, Xiong G, Cao Z, et al. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017;407:57–65. doi: 10.1016/j.canlet.2017.08.006
   PubMed Web of Science ®Google Scholar
• Hoppe MM, Sundar R, Tan DSP, et al. Biomarkers for homologous recombination deficiency in cancer. J Natl Cancer Inst. 2018;110(7):704–713. doi: 10.1093/jnci/djy085
   PubMedGoogle Scholar
• Wang Z, Jensen MA, Zenklusen JC. A practical guide to the cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111–141.
   PubMedGoogle Scholar
• Clough E, Barrett T. The gene expression Omnibus database. Methods Mol Biol. 2016;1418:93–110.
   PubMedGoogle Scholar
• Aaltonen LA, Abascal F, Abeshouse A. ICGC/TCGA pan-cancer analysis of whole genomes consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578(7793):82–93. doi: 10.1038/s41586-020-1969-6
   PubMed Web of Science ®Google Scholar
• Vander Velde N, Guerin A, Ionescu-Ittu R, et al. Comparative effectiveness of non-cisplatin first-line therapies for metastatic urothelial carcinoma: phase 2 IMvigor210 study versus US patients treated in the Veterans Health Administration. Eur Urol Oncol. 2019;2(1):12–20. doi: 10.1016/j.euo.2018.07.003
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi: 10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612–2612. doi: 10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338–354. doi: 10.1016/j.cell.2018.03.034
   PubMed Web of Science ®Google Scholar
• Miao YR, Zhang Q, Lei Q, et al. ImmuCellAI: a unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci. 2020;7(7):1902880. doi: 10.1002/advs.201902880
   Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi: 10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9(1):559–559. doi: 10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523–1523. doi: 10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Geeleher P, Cox N, Huang RS. pRrophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 2014;9:e107468. doi: 10.1371/journal.pone.0107468
   PubMed Web of Science ®Google Scholar
• Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(D1):D955–961. doi: 10.1093/nar/gks1111
   PubMed Web of Science ®Google Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123–123. doi: 10.1186/s13148-019-0730-1
   PubMed Web of Science ®Google Scholar
• Hanko M, Grendár M, Snopko P, et al. Random forest-based prediction of outcome and mortality in patients with traumatic brain injury undergoing primary decompressive craniectomy. World Neurosurg. 2021;148:e450–e458. doi: 10.1016/j.wneu.2021.01.002
   PubMed Web of Science ®Google Scholar
• Cheung-Lee WL, Link AJ. Genome mining for lasso peptides: past, present, and future. J Ind Microbiol Biotechnol. 2019;46(9–10):1371–1379. doi: 10.1007/s10295-019-02197-z
   PubMed Web of Science ®Google Scholar
• Lei Y, Yu T, Li C, et al. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer. J Cell Mol Med. 2021;25(2):1198–1206. doi: 10.1111/jcmm.16188
   PubMed Web of Science ®Google Scholar
• Akoglu H. User’s guide to correlation coefficients. Turk J Emerg Med. 2018;18:91–93. doi: 10.1016/j.tjem.2018.08.001
   PubMed Web of Science ®Google Scholar
• Telli ML, Timms KM, Reid J, et al. Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with Triple-negative breast cancer. Clin Cancer Res. 2016;22(15):3764–3773. doi: 10.1158/1078-0432.CCR-15-2477
   PubMed Web of Science ®Google Scholar
• Gou R, Dong H, Lin B. Application and reflection of genomic scar assays in evaluating the efficacy of platinum salts and PARP inhibitors in cancer therapy. Life Sci. 2020;261:118434. doi: 10.1016/j.lfs.2020.118434
   PubMed Web of Science ®Google Scholar
• Sharma P, Barlow WE, Godwin AK, et al. Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313). Ann Oncol. 2018;29(3):654–660. doi: 10.1093/annonc/mdx821
   PubMed Web of Science ®Google Scholar
• Pilehchian Langroudi M, Nikbakhsh N, Samadani AA, et al. FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma. J Cell Commun Signal. 2017;11(1):69–75. doi: 10.1007/s12079-016-0355-5
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhou B, Luo H, et al. ZnAs@SiO2nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Theranostics. 2019;9(15):4391–4408. doi: 10.7150/thno.32462
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C, Loi S, Garaud S, et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873–2892. doi: 10.1172/JCI67428
   PubMed Web of Science ®Google Scholar
• Kuczek DE, Larsen AMH, Thorseth ML, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7(1):68–68. doi: 10.1186/s40425-019-0556-6
   PubMed Web of Science ®Google Scholar
• Chen Z, Wu T, Yan Z, et al. Identification and validation of an 11-Ferroptosis related gene signature and its correlation with immune checkpoint molecules in Glioma. Front Cell Dev Biol. 2021;9:652599. doi: 10.3389/fcell.2021.652599
   PubMed Web of Science ®Google Scholar
• Chen X, Jin Y, Gong L, et al. Bioinformatics analysis finds immune gene markers related to the prognosis of bladder cancer. Front Genet. 2020;11:607–607. doi: 10.3389/fgene.2020.00607
   PubMed Web of Science ®Google Scholar
• Orthwein A, Noordermeer SM, Wilson MD, et al. A mechanism for the suppression of homologous recombination in G1 cells. Nature. 2015;528(7582):422–426. doi: 10.1038/nature16142
   PubMed Web of Science ®Google Scholar
• Zhao X, Wei C, Li J, et al. Cell cycle-dependent control of homologous recombination. Acta Biochim Biophys Sin (Shanghai). 2017;49(8):655–668. doi: 10.1093/abbs/gmx055
   PubMed Web of Science ®Google Scholar
• Jia Y, Tian Q, Yang K, et al. A pan-cancer analysis of clinical prognosis and immune infiltration of CKS1B in human tumors. Biomed Res Int. 2021;2021:1–25. doi: 10.1155/2021/5862941
   PubMed Web of Science ®Google Scholar
• Shrestha S, Yang CD, Hong HC, et al. Integrated MicroRNA–mRNA analysis reveals miR-204 inhibits cell proliferation in gastric cancer by targeting CKS1B, CXCL1 and GPRC5A. Int J Mol Sci. 2017;19(1):87–87. doi: 10.3390/ijms19010087
   PubMed Web of Science ®Google Scholar
• He Y, Peng L, Li J, et al. TPX2 deficiency leads to spindle abnormity and meiotic impairment in porcine oocytes. Theriogenology. 2022;187:164–172. doi: 10.1016/j.theriogenology.2022.04.031
   PubMed Web of Science ®Google Scholar
• Bassett EA, DeNizio J, Barnhart-Dailey MC, et al. HJURP uses distinct CENP-A surfaces to recognize and to stabilize CENP-A/histone H4 for centromere assembly. Dev Cell. 2012;22(4):749–762. doi: 10.1016/j.devcel.2012.02.001
   PubMed Web of Science ®Google Scholar
• Serafim RB, Cardoso C, Di Cristofaro LFM, et al. HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells. Cancer Gene Ther. 2020;27(5):319–329. doi: 10.1038/s41417-019-0103-0
   PubMed Web of Science ®Google Scholar
• Nguyen LWM, Martens J, Van HA, et al. Pan-cancer landscape of homologous recombination deficiency. Nat Commun. 2020;11(1):5584–5584. doi: 10.1038/s41467-020-19406-4
   PubMed Web of Science ®Google Scholar
• Babushkina NP, Postrigan AE, Kucher AN. Involvement of variants in the genes encoding BRCA1-associated Genome surveillance complex (BASC) in the development of human common diseases. Mol Biol (Mosk). 2021;55(2):278–296. doi: 10.1134/S0026893321020047
   Web of Science ®Google Scholar
• Wang Y, Cortez D, Yazdi P, et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 2000;14(8):927–939. doi: 10.1101/gad.14.8.927
   PubMed Web of Science ®Google Scholar
• Jiang M, Jia K, Wang L, et al. Alterations of DNA damage repair in cancer: from mechanisms to applications. Ann Transl Med. 2020;8(24):1685–1685. doi: 10.21037/atm-20-2920
   PubMed Web of Science ®Google Scholar
• Jiang X, Li X, Li W, et al. PARP inhibitors in ovarian cancer: sensitivity prediction and resistance mechanisms. J Cell Mol Med. 2019;23(4):2303–2313. doi: 10.1111/jcmm.14133
   PubMed Web of Science ®Google Scholar
• Oliver GR, Hart SN, Klee EW. Bioinformatics for clinical next generation sequencing. Clin Chem. 2015;61(1):124–135. doi: 10.1373/clinchem.2014.224360
   PubMed Web of Science ®Google Scholar